March 16, 2017
FY 2018 Budget Proposes Doubling of User Fees for FDA’s Medical Product Premarket Reviews
The Trump administration is looking to double the amount of user fees collected by the FDA from companies it regulates for the agency's premarket reviews of medical products, according to the fiscal year (FY) 2018 federal government...
You must be a subscriber to access this information. If you are a subscriber, please login. Not Yet A Subscriber? Click here to register for a free trial or contact Client Services at 800-677-3789 to activate your subscription.